Showing results 4 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Homologous and heterologous boosting with third-dose BNT162b2 and CoronaVac: a randomized trial (Cobovax study) Proceeding/Conference:Options for the Control of Influenza XI | 2022 | ||
2020 | |||
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Journal:Antiviral Research | 2020 |